Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 53.00
+0.40 (0.75%)
Dec 5, 2025, 1:30 PM CST
Pharmosa Biopharm Revenue
Pharmosa Biopharm had revenue of 4.00M TWD in the quarter ending September 30, 2025, a decrease of -90.23%. This brings the company's revenue in the last twelve months to 136.72M, up 170.62% year-over-year. In the year 2024, Pharmosa Biopharm had annual revenue of 167.57M, down -46.72%.
Revenue (ttm)
136.72M
Revenue Growth
+170.62%
P/S Ratio
50.04
Revenue / Employee
n/a
Employees
39
Market Cap
6.84B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 34.99M |
| PharmaEssentia | 13.82B |
| Lotus Pharmaceutical | 18.66B |
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Oneness Biotech | 117.33M |
| Lumosa Therapeutics | 42.59M |
| Center Laboratories | 1.57B |
| Pegavision | 6.90B |